Docosahexaenoic acid: membrane modification and neurotrophic mechanisms

ARTICLE

ocl.2011.0409

Auteur(s) : Hee-Yong Kim hykim@nih.gov

Laboratory of Molecular Signaling, DICBR, NIAAA, NIH, 5625 Fishers Lane, Bethesda, MD 20892-9410 USA

DHA and membrane modification

DHA is highly concentrated in neuronal cells, particularly in aminophospholipids such as phosphatidylethanolamine (PE) and phosphatidylserine (PS) (Salem et al., 2001). PS represents the major acidic phospholipid in eukaryotic cell membranes and participates in important signaling processes (Kim, 2007; Kim et al., 2010). In animal cells, PS is synthesized from PC or PE by the serine base exchange reaction catalyzed by PS synthases (PSS) (Vance, 2008). The high compositional profile of DHA in PS can be attributed to the molecular species specificity in the PS synthesis or degradation, although deacylation/reacylation reactions may also contribute (Lands, 1960). The PS decarboxylation (PSD) occurs most preferably for 18:0, 22:6-PS (Kevala and Kim, 2001), suggesting that unfavored PS degradation of DHA-containing PS species is an unlikely cause for the high level of DHA species in PS. We have also demonstrated that 18:0,22:6-PC or PE is the best substrate for PSS1 (Kim et al., 2004) or PSS2 (Wen and Kim, 2007), respectively, which contributes to the concentration of DHA in PS. In neural tissues where DHA is highly concentrated, PS levels are also high, suggesting that DHA is a positive modulator for PS synthesis (Kim, 2008). Indeed, DHA increases the PS content in neuronal cells primarily due to the increased PS biosynthesis and accumulation of 18:0,22:6-PS (Garcia et al., 1998). Among many cells in culture, the DHA-induced PS increase occurs uniquely in neuronal cells (Guo et al., 2007). In contrast, depletion of DHA has a profound effect on the PS accumulation specifically in neural tissues where DHA is highly enriched (Kim, 2008; Hamilton et al., 2000). N-3 fatty acid deficiency results in depletion of DHA, and thus PC and PE species containing DHA, the most preferred substrates for PS synthesis. The compensatory increase of docosapentaenoic acid (DPAn-6, 22:5n-6) is not sufficient to fully recover the PS level (Hamilton et al., 2000), since DPAn-6-containing phospholipids are less effective substrates for PS synthesis in comparison to DHA-containing phospholipids (Kim et al., 2004; Wen and Kim, 2007). N-3 fatty acid deficiency does not significantly affect microsomal PSS activity itself (figure 1), indicating that the observed PS decrease after n-3 fatty acid depletion is primarily due to the limited availability of DHA-containing phospholipids, the best substrates for PSS. In neuronal cells in culture, both DHA and DPAn-6 supplementation significantly increase the PS content (figure 2A). However, DPAn-6-induced PS increase is less than 80% of the PS increase after DHA enrichment. The individual phospholipid molecular species distribution shows that 18:0, 22:6-PS increases more than 18:0, 22:5n-6 species after enrichment with DHA and DPAn-6 at an equal concentration (figure 2B). As the proportion of DHA with respect to DPAn-6 decreases, a gradual reduction in the total PS content is observed. Findings from both in vivo n-3 fatty acid depletion and in cell supplementation with DHA or DPAn-6 consistently indicate that neuronal PS accumulation is dependent on the DHA content. Indeed, DHA enrichment is a unique mechanism to alter the PS pool, which is limited to neuronal membranes. The plasma membrane and recycling endosomes are the major sites where PS localizes in the cytoplasmic face (Calderon and Kim, 2008), suggesting that these membranes can offer specific target surface for cytosolic signaling proteins that interact with PS.

DHA and neuronal survival

The biochemical characteristics of DHA to increase PS have significant implication in neuronal survival. Supplementation of neuronal cells with DHA reduces caspase-3 activation, a hallmark for apoptotic cell death, induced by serum deprivation (figure 3). This protection occurs only when the PS pool is allowed to expand as the supplementation with oleic acid (18:1n-9, OA) or DHA under a serine-free condition is not effective, indicating that DHA prevents apoptotic cell death in a PS-dependent manner (Kim et al., 2000). Adverse effects of n-3 fatty acid deficiency on cell survival is readily apparent due to the differential capacity of DHA and DPAn-6 to accumulate PS in neuronal membranes following in vivo dietary manipulation of n-3 fatty acid intake or supplementation of neuronal cells in culture (Akbar et al., 2005). Neuronal apoptosis induced by staurosporine (ST) treatment is another apoptotic model where DHA inhibited cell death due to its ability to promote PS accumulation in cell membranes (Akbar and Kim, 2002). These findings indicate a unique role of DHA in neuronal survival through modulating membrane PS levels which in turn can influence PS-dependent signaling events.

DHA and neurodevelopment

The importance of developmental accretion of DHA in hippocampus-dependent function such as learning and memory in humans and animals has been well documented (Willatts et al., 1998; Birch et al., 2000; Gamoh et al., 1999; Moriguchi et al., 2000). Previously, we have demonstrated that DHA uniquely increases the population of neurons with longer neurites and a higher number of branches in rat and mouse embryonic hippocampal neuronal cultures (Moriguchi et al., 2000; Cao et al., 2009). Similar stimulating effects of DHA on neurite growth can be also observed in cortical neurons (figure 4). It has been demonstrated in mouse hippocampal cultures that DHA promotes not only neurite growth but also synaptogenesis and the expression of pre- and post-synaptic proteins such as synapsins and N-methyl-D-aspartate (NMDA) and α-amino-3-hydroxy-5-methylisoxazole (AMPA) receptors, enhancing glutamatergic synaptic activity (Cao et al., 2009). Moreover, developmental depletion of DHA results in reduced expression of those synaptic proteins in the hippocampi of 18-day-old mice. Such reduction significantly impairs long-term potentiation (LTP), a well characterized form of synaptic plasticity similar to that involved in hippocampus-based learning and memory. Rat hippocampal neurons similarly increase neurite growth and synaptogenesis after DHA treatment (figure 5). Recently, N-docosahexaenoylethanolamide (Synaptamide, DEA) has been identified as a bioactive DHA metabolite endogenously formed in the brain. This amide form of DHA metabolite is a potent mediator for DHA-induced neurite growth, synaptogenesis and glutamatergic synaptic function (Kim et al., 2011), and thus named as synaptamide (Kim et al., 2012). The formation of synaptamide as well as its unique signaling is expected to play a significant role in neuronal development. In addition, DHA-mediated modification of membrane PS content may also serve as an important mechanism for DHA-induced neuritogenesis, synaptogenesis and synaptic function, as in the case of neuronal survival.

Membrane modification and cell signaling

The biochemical function of DHA to promote PS accumulation in the central nervous system is an important underpinning of the maintenance of neuronal survival, since the protection by DHA is PS-dependent. Specifically, facilitated PS-dependent Akt translocation is a target event where the protective effect of DHA on neuronal survival is derived (Akbar, et al., 2005). It is well established that Akt activation requires phosphatidylinositol 3,4,5-trisphosphate (PIP₃)-dependent membrane translocation and phosphorylation (Alessi and Cohen, 1998). Growth factor receptor stimulation activates PI3 kinase (PI3K), producing PIP₃ which in turn recruits cytosolic Akt to the plasma membrane through the interaction with the pleckstrin homology domain (PH) of Akt. We have recently demonstrated a novel molecular mechanism revealing that Akt activation is critically dependent on the interaction with not only well-recognized PIP₃ but also PS (Huang et al., 2011). In addition, we have provided a molecular basis for the DHA-promoted neuronal survival by demonstrating that Akt translocation and activation is affected by Akt-PS interaction in a PS concentration-dependent manner. The decreased PS content in neural membranes due to DHA depletion (Hamilton et al., 2000) would diminish Akt activation and thus increase neuronal cell death, particularly under adverse conditions where PIP₃ is limited (Akbar et al., 2005; Akbar and Kim, 2002). In contrast, increasing the plasma membrane PS content by DHA supplementation would facilitate cellular Akt activation, improving neuronal survival. Considering the necessity of PS-Akt interaction for Akt activation, DHA's capacity to increase PS is of crucial importance to sustain survival of neurons particularly under distress (figure 5).

Raf-1 activation, which is an upstream event of MAP kinase activation, is known to play an important role in transducing signals of many growth factors, and thus influencing cell survival, differentiation and proliferation (Kim et al., 2010). The importance of Raf-1 activation in neurite growth is evident as Neuro 2A cells expressing a constitutively active Raf-1 mutant (Raf-1K375M) shows considerably improved neurite outgrowth in comparison to the cells expressing wild type Raf-1 (figure 6). Although the mechanism of Raf-1 activation is complex, translocation of Raf-1 to the membrane and subsequent phosphorylation are considered to be important steps for its activation (Stokoe et al., 1994). It has been shown that Raf-1 kinase contains distinct binding domains for acidic phospholipids (Improta-Brears et al., 1999), and therefore, membrane localization of Raf-1 may be dependent on the concentration of PS modulated by DHA. According to our previous finding, membrane translocation of Raf-1 in response to BDNF is indeed significantly enhanced by DHA enrichment in Neuro 2A cells (Kim et al., 2000). Therefore, it is conceivable that Raf-1 activation facilitated by DHA-induced PS increase in the plasma membrane at least in part contributes to the neuritogenesis and synaptogenesis mediated by DHA.

Conclusion

One of the specific biochemical functions of DHA in the central nervous system is to increase the PS content primarily through the accumulation of the molecular species 18:0,22:6-PS. Preferred microsomal PS synthesis from 18:0,22:6-PC appears to be a mechanism for the enrichment of this PS species. Depletion of DHA by n-3 fatty acid deficiency has a significant negative impact on the PS accumulation in neuronal cells due to the fact that DPAn-6, the substitute for DHA under this condition, does not fully support the original level of PS biosynthesis. DHA supports neuronal survival in a PS-dependent manner, particularly under adverse conditions. The PS-dependent acceleration of Akt translocation is particularly vital under suboptimal conditions where the survival signal is compromised. DHA also promotes neurite growth, synaptogenesis and expression of synaptic proteins, improving synaptic function, at least partly through facilitating Raf-1 activation. Figure 7 summarizes membrane PS-related signaling mechanisms invloved in DHA-mediated neuroprotection. Taken together, one of the primary biological functions of DHA is the maintenance of PS accumulation in the central nervous system due to its ability to positively modulate PS biosynthesis. In this regard, the loss of PS by n-3 fatty acid depletion and the resulting increased susceptibility to cell death and inadequate cellular development may have significant implications in neuronal dysfunction.

Acknowledgments

This research was supported by the Intramural Research Program of the NIAAA, NIH.

References

Akbar M, Kim H.Y. Protective effects of docosahexaenoic acid (DHA) in staurosporine-induced apoptosis: Involvement of wortmanin-sensitive pathway. J Neurochem 2002 ; 82 : 655-665.

Akbar M, Calderon F, Wen Z, Kim H.Y. Docosahexaenoic Acid: A positive modulator of Akt signaling in neuronal survival. Proc Natl Acad Sci USA 2005 ; 102 : 10858-10863.

Alessi DR, Cohen P. Mechanism of activation and function of protein kinase B. Curr Opin Genet Dev 1998 ; 8 : 55-62.

Birch EE, Garfield S, Hoffman DR, Uauy RD, Birch D.G. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol 2000 ; 42 : 174-181.

Calderon F, Kim H.Y. Detection of intracellular phosphatidylserine in living cells. J Neurochem 2008 ; 104 : 1271-1279.

Cao D, Kevala K, Jun S, Lovinger D, Kim H.Y. Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function. J Neurochem 2009 ; 111 : 510-521.

Gamoh S, Hashimoto M, Sugioka K, et al. Chronic administration of docosahexaenoic acid improves reference memory-related learning ability in young rats. Neuroscience 1999 ; 93 : 237-241.

Garcia M, Ward G, Ma YC, Salem N Jr, Kim HY. Effect of docosahexaenoic acid on the synthesis of phosphatidylserine in rat brain microsomes and C6 glioma cells. J Neurochem 1998; 70: 24-30.

Guo M, Stockert L, Akbar M, Kim H.Y. Neuronal specific increase of phosphatidylserine by docosahexaenoic acid. J. Mol. Neurosci 2007 ; 33 : 67-73.

Hamilton J, Greiner R, Salem N Jr, Kim HY. N-3 fatty acid deficiency decreases phosphatidylserine accumulation selectively in neuronal tissues. Lipids 2000; 35: 863-9.

Huang BX, Akbar M, Kevala K, Kim H.Y. Phosphatidylserine as a critical modulator of Akt activation. J. Cell Biol 2011 ; 192 : 979-992.

Improta-Brears T, Ghosh S, Bell R.M. Mutational analysis of Raf-1 cysteine rich domain: requirement for a cluster of basic aminoacids for interaction with phosphatidylserine. Mol Cell Biochem 1999 ; 198 : 171-178.

Kevala HJ, Kim H.Y. Determination of substrate preference in phosphatidylserine decarboxylation by liquid chromatography-electrospray mass spectrometry. Anal Biochem 2001 ; 292 : 130-138.

Kim HY, Akbar M, Lau A, Edsall L. Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3): Role of phosphatidylserine in antiapoptotic effect. J Biol Chem 2000 ; 275 : 35215-35223.

Kim HY, Bigelow J, Kevala J.H. Substrate preference in phosphatidylserine biosynthesis for docosahexaenoic acid containing species. Biochemistry 2004 ; 43 : 1030-1036.

Kim H.Y. Novel metabolism of docosahexaenoic acid in neural cells. J Biol Chem 2007 ; 282 : 18661-18665.

Kim H.Y. Biochemical and biological functions of docosahexaenoic acid in the nervous system: modulation by ethanol. Chem Phys Lipids 2008 ; 153 : 34-36.

Kim HY, Akbar M, Kim Y.S. Phosphatidylserine-dependent neuroprotective signaling promoted by docosahexaenoic acid. Prostaglandins Leukot Essent Fatty Acids 2010 ; 82 : 165-172.

Kim HY, Lee J, Moon HS, et al. Metabolism of docosahexaenoic acid to N -docosahexaenoylethanolamide in hippocampal neurodevelopment. Biochem J 2011 ; 435 : 327-336.

Kim HY, Spector AA, Xiong ZM. A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development. Prostaglandins Other Lipid Med. (In Press). 2012.

Lands W. E. M. Metabolism of glycerolipids. J Biol Chem 1960; 235: 2233-7.

Moriguchi T, Greiner RS, Salem N Jr Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J Neurochem 2000 ; 75 : 2563-2573.

Salem N Jr Litman B, Kim HY, Gawrisch K. Mechanism of action of docosahexaenoic acid in the nervous system. Lipids 2001 ; 36 : 945-959.

Stokoe D, Macdonald SG, Cadwallader K, Symons K, Hancock JF. Activation of Raf as a result of recruitment to the plasma membrane. Science 1994; 264: 1463-67; Correction (1994) Science 266: 1792-3.

Vance J.E. Phosphatidylserine and phosphatidylethanolamine in mammalian cells: two metabolically related aminophospholipids. J Lipid Res 2008 ; 49 : 1377-1387.

Wen Z, Kim H.Y. Inhibition of phosphatidylserine biosynthesis by ethanol in developing rat brain. J Neurosci Res 2007 ; 85 : 1568-1578.

Willatts P, Forsyth JS, Di Modugno MK, Varma S, Colvin M. Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet 1998 ; 352 : 688-691.